Company records / luxnabiotech.co.jp

Luxna Biotech Co., Ltd.

Luxna Biotech Co., Ltd. (luxnabiotech.co.jp): no confident changes recorded yet; website history since November 2026. Homepage last checked 12 November 2026.

First recorded website

Observed 12 November 2026

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

ルクサナバイオテク（Luxna Bioetch）はアカデミアで蓄積された核酸医薬品要素技術（架橋型修飾核酸・毒性低減技術）を基礎として、より安全かつ効果的な核酸医薬品の実用化を進めて医薬品素材提供やアカデミアの創薬研究を加速させることを通じ、アンメットメディカルニーズに応えることを目指します。【社名の由来】修飾核酸群（XNA）を活用した核酸医薬品の開発を進めることで、まだ治療薬がなく苦しんでいる患

current websiteHistorical capture not publicly availableLink to first observation

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

No changes recorded yet. Missing observations do not mean the company has not changed.

Companies in the same space

Other funded startups with the most similar descriptions of what they do, or classified under “Early-stage small-molecule and antibody drugs”. This does not mean they compete directly.

Lexeo Therapeutics lexeotx.com
CCX Pharma ccx.tech
ProLynx prolynxinc.com
BlossomHill Therapeutics bhtherapeutics.com
Star Therapeutics star-therapeutics.com
Uncommon Therapeutics uncommontherapeutics.com

Cite this record

StartupHistory, “Luxna Biotech Co., Ltd.” company record, https://startuphistory.org/c/luxnabiotech.co.jp

Machine-readable: /c/luxnabiotech.co.jp.json. How changes are found: method.